The Stanley Medical Research Institute (SMRI) is a nonprofit organization dedicated to advancing research on the causes and treatments of schizophrenia and bipolar disorder. Since its establishment in 1989, SMRI has provided over $550 million in funding for research projects in more than 30 countries worldwide.
Through their Treatment Trial Grants program, SMRI supports the evaluation of various medications for their effectiveness in treating schizophrenia and bipolar disorder, with a focus on generic and off-label medications. Additionally, SMRI conducts extensive brain research, offering postmortem samples and datasets for studying neuropathology, genetics, and gene expression in relation to these mental health conditions.
Generated from the website